UroGen Pharma Ltd. (URGN) Total assets 2016–2025
UroGen Pharma Ltd. (URGN) total assets at each fiscal year-end, per SEC filings.
$200.5MFY2025 · since FY2016: $23.1M → $200.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $200.5M | -29.8% |
| FY2024 | $285.7M | +60.2% |
| FY2023 | $178.3M | +31.5% |
| FY2022 | $135.6M | +13.3% |
| FY2021 | $119.7M | -1.9% |
| FY2020 | $122.0M | -39.7% |
| FY2019 | $202.4M | +95.4% |
| FY2018 | $103.6M | +37.1% |
| FY2017 | $75.5M | +227.7% |
| FY2016 | $23.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More URGN financial trends
URGN RevenueURGN Net incomeURGN Net marginURGN Gross profitURGN Gross marginURGN Operating incomeURGN Operating marginURGN Operating cash flowURGN Free cash flowURGN Capital expendituresURGN Return on equityURGN Stock buybacksURGN Dividends paidURGN Total liabilitiesURGN Shareholders’ equityURGN overview →